TERT and acute myeloid leukemia: In the present study we aimed to analyse AML patients in terms of the presence of FLT3-ITD and/or NPM1 gene mutations, telomere length and genetic variability within catalytic subunit of telomerase (TERT) in younger and old AML patients with respect to the clinical data, including overall survival (OS).